AZ, Lilly's BACE Inhibitor Clears Safety Hurdle And Raises Class Hopes
This article was originally published in The Pink Sheet Daily
Executive Summary
All clear from monitoring board means firms will roll into the Phase III portion of the AMARANTH trial.